Neisseria meningitidis is a major causative agent of bacterial septicemia and meningitis in humans. Currently, there are no vaccines to prevent disease caused by strains of N.meningitidis serogroup B. The Class 1 Outer Membrane Protein (OMP) has been named porA which is a cation selective transmembrane protein of 45 KDa that forms trimeric pore in the meningococcal outer membrane. PorA from serogroup B N. meningitidis was cloned into prokaryotic expression vector pBAD-gIIIA. Recombinant protein was expressed with arabinose and affinity purified by Ni-NTA agarose, SDS-PAGE and western blotting were performed for protein determination and verification. BALB/c mice were immunized subcutaneously with purified rPorA together with alum adjuvant. Serum antibody responses to serogroups B N.meningitidis were determined by ELISA. Serum IgG response significantly increased in the group immunized with rPorA together with alum adjuvant in comparison with control groups. These results suggest that rPorA can be a potential vaccine candidate for serogroup B N.meningitidis.
unattractive vaccine candidates, since they exhibit extreme antigenic heterogeneity (7) . The function of the class1 OMP is unknown. The structural gene for this protein has recently been cloned and sequenced (8) , and it appears that the protein is structurally related to the gonococcal porins and to class 2 OMP (9) . Therefore, in addition class 1 OMP may have a pore function. The class 1 OMP has been named PorA and the corresponding gene has been designated porA (10) .
Monoclonal antibodies have been raised against the class 1 and class 2/3 OMPs; in both cases, antibodies with bactericidal activity have been obtained. Thus making this protein the prime vaccine candidate for meningococcus group B (11).
The two PorA variable regions (VR1 and VR2) that confer the subtypes are especially important because they elicit bactericidal antibodies in humans (12) . Consequently, a number of meningococcal vaccines under development contain the PorA protein as a major component (13) . In humans, the protein elicits a more protective immune response than any other meningococcal surface protein (14) . Much of this evidence comes from the clinical evaluation of OMV vaccines in which PorA is the immuno-dominant antigen (15 
DNA isolation
Plasmid DNA was prepared by using a Qiagen plasmid DNA kit (Qiagen GmbH, Dusseldorf, Germany) according to the manufacturer's instructions. Genomic DNA from N. meningitidis was prepared using a genomic DNA extraction kit.
Amplification of porA
The porA gene was amplified from N. and bradford protein assay with bovine serum albumin as standard.
SDS-PAGE and western blotting
After purification, the expressed protein was 
Mouse immunization
Groups of seven weeks-old BALB/c female mice were immunized subcutaneously with 50 µg of purified rPorA and immunized with 50 µg rPorA mixed with alum adjuvant for three doses at weeks 0, 2 and 4. Control groups consisted of mice receiving PBS alone. Sera were collected at weeks 0, 2, 4 and 6 to determine the antibody response.
Aliquots of serum were stored at-20 o C for further use.
Determination of serum IgG and its subclasses
The IgG antibody responses to N. meningitidis serogroup B whole cells were determined by wholecell ELISA as previously described on pooled sera collected two weeks after the last immunization.
The IgG, IgG1, IgG2a and IgG2b antibody 
Statistical analyses
The statistical analyses were performed by Graphpad Prism 5, following normalization of the data. One-way ANOVA and t-tests were used to check for differences between data sets. P values (≤0.05) were considered statistically significant.
Results

Physical and chemical properties of PorA
The physical and chemical properties of PorA beta turn (Figure 1 ).
Hydrophilicity prediction of PorA
Hydrophilicity of PorA was predicted utilizing online service (http://web.expasy.org/protscale/).
The results showed that the site of Glu is the most hydrophilic (Score:-3.500) and Phe the most hydrophobic (Score: 2.800) (Figure 2 ). We came to the conclusion that the PorA is a hydrophilic protein. 
Western blot analysis
Western blot analysis was performed to confirm the expressed protein, the 45 kDa protein observed in SDS-PAGE, was confirmed as rPorA protein by western blot analysis using Anti-6XHis tag ( Figure 7 ). As mentioned in our results, IgG titres exponentially and significantly increased in the immunized group compared to the control group.
Serum responses after immunization with rPorA
Thus, the immunogenicity of PorA and the significant difference (p< 0.001) of these titres could make rPorA a potential adjuvant.
